Temoside 250 Capsule
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Temoside 250 Capsule contains temozolomide, an alkylating cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of certain types of brain tumour, usually when the tumour returns or worsens after standard treatment, and it may be prescribed by the doctor for other conditions such as malignant melanoma. It is described as entering the brain tissue and damaging the DNA and RNA of cancer cells, and is taken on an empty stomach.
Product Information
The following description reflects information associated with temozolomide and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of certain brain tumours, particularly when they return or worsen after standard treatment
- Described as also prescribed for malignant melanoma and for other conditions as the doctor sees fit
- Described as damaging the DNA and RNA of cancer cells to stop their growth and multiplication
Described Dosage & Administration
- Taken by mouth on an empty stomach, following the doctor’s instructions
- The dose and directions are set by the doctor and may change according to treatment progress
Described Side Effects
Commonly described side effects include:
- Nausea and vomiting
- Constipation and diarrhoea
- Headache
- Tiredness (fatigue) and weakness
- Coordination disorder and dizziness
- Fever
- Hair loss
- Difficulty sleeping (insomnia)
- Loss of appetite
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Regular blood tests are described as carried out during treatment and should be cooperated with
- The doctor should be told about all past and current medicines
- It is described as not for use during pregnancy or breastfeeding
- Conception should be prevented during treatment and for some months afterwards
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains temozolomide and is used to treat certain brain tumours, particularly when they return or worsen after standard treatment, and malignant melanoma. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth on an empty stomach, following the doctor’s instructions. The dose may change according to treatment progress.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.